Short QT Syndrome and Early Repolarization Syndrome
When repolarization is too fast or too heterogeneous, the ventricle becomes vulnerable to fibrillation.
Short QT Syndrome (SQTS) and Early Repolarization Syndrome (ERS) sit at the opposite end of the repolarization spectrum from Long QT. Instead of prolonged repolarization creating pauses that allow afterdepolarizations, these conditions feature abbreviated or heterogeneous repolarization that creates vulnerability to ventricular fibrillation through a completely different mechanism.
The common thread is a shortened effective refractory period. When tissue recovers excitability too quickly, the wavelength of any reentrant circuit shrinks. Smaller wavelengths mean smaller circuits can sustain themselves. The result is a ventricle that can fibrillate with minimal provocation.
Short QT Syndrome: The Genetics
SQTS is caused by mutations that accelerate repolarization. Two classes of mutations achieve this:
Gain-of-function potassium channel mutations increase outward repolarizing current. More potassium leaves the cell during repolarization, so the action potential terminates sooner. SQT1 involves KCNH2 (encoding the IKr channel), SQT2 involves KCNQ1 (IKs), and SQT3 involves KCNJ2 (IK1).
Loss-of-function calcium channel mutations reduce inward depolarizing current during the plateau. With less calcium current holding the membrane positive, repolarization accelerates. SQT4 involves CACNA1C and SQT5 involves CACNB2 (the same genes implicated in Brugada syndrome, reflecting mechanistic overlap).
Both classes produce the same end result: the action potential duration shortens, the effective refractory period abbreviates, and the tissue becomes excitable again too soon after each beat.
The Wavelength Problem
Reentry requires a circuit length that exceeds the wavelength of the electrical impulse. Wavelength equals conduction velocity multiplied by the refractory period. If conduction velocity stays constant but the refractory period drops from 250 ms to 180 ms, the wavelength shrinks proportionally.
A shorter wavelength means the impulse can complete a smaller circuit and still find recovered tissue ahead of it. The excitable gap (the portion of the circuit that has already recovered and is ready to be re-excited) becomes disproportionately large relative to the circuit. This makes it easy for wavefronts to fragment and sustain multiple small reentrant circuits simultaneously. That is fibrillation.
In SQTS, ventricular ERPs measured in the EP lab are often below 200 ms (normal is 230-280 ms). VF is easily induced with programmed stimulation, sometimes with a single extrastimulus.
Left: normal action potential with APD ~300 ms and ERP ~260 ms. Right: Short QT with APD ~200 ms and abbreviated ERP ~180 ms. The large excitable gap (teal) relative to circuit length allows small reentrant wavefronts to sustain themselves.
The ECG of Short QT
The defining feature is a corrected QT interval below 340 ms (some criteria use < 360 ms in patients with symptoms or family history). The absolute QT interval may be strikingly short, often below 300 ms even at normal heart rates.
T waves are tall, peaked, and narrow-based. Rapid repolarization produces a steep voltage change over a brief time, generating a sharp, pointed T wave. This is the visual signature of accelerated Phase 3.
The ST segment is very short or absent. The T wave begins almost immediately after the QRS complex because there is minimal plateau phase before repolarization begins its descent.
A distinctive feature of SQTS is that the QT interval fails to shorten appropriately with increasing heart rate. In normal physiology, the QT adapts significantly to rate changes. In SQTS, the QT is already near its minimum and has little room to shorten further. This produces a "flat" QT-rate relationship.
Diagnosis and Risk
SQTS is extremely rare. Fewer than 200 cases have been reported worldwide. The rarity makes population-level risk stratification difficult.
Clinical triggers for suspicion include a family history of sudden cardiac death at a young age, unexplained cardiac arrest, or atrial fibrillation presenting unusually early (the short atrial refractory periods predispose to AF as well). In many cases, VF is the first clinical presentation, often in adolescents or young adults.
In the EP lab, ventricular effective refractory periods are characteristically short (often < 200 ms at multiple RV sites). VF is easily inducible, sometimes with a single premature extrastimulus at long coupling intervals. This ease of induction correlates with clinical risk.
Early Repolarization: Pattern vs Syndrome
The early repolarization pattern is defined as J-point elevation of at least 1 mm (0.1 mV) in two or more contiguous inferior or lateral leads, with notching or slurring of the terminal QRS. This pattern is common: it appears in 5-10% of the general population, with higher prevalence in young men and athletes.
For decades, early repolarization was considered universally benign. Studies in 2008 challenged this assumption by demonstrating a statistical association between the inferior ER pattern and idiopathic VF. The association is real but the absolute risk is vanishingly small for any individual.
Early Repolarization Syndrome (ERS) is the rare malignant form. It is diagnosed only retrospectively, in patients who have the ER pattern AND have survived idiopathic VF or unexplained cardiac arrest. The pattern alone, without an arrhythmic event, remains a benign finding in the overwhelming majority of individuals who carry it.
Mechanism of Malignant Early Repolarization
The mechanism parallels Brugada syndrome. In certain individuals, a prominent transient outward potassium current (Ito) causes regional epicardial shortening of Phase 2 (the plateau). The epicardial action potential loses its dome while the endocardium retains it.
This creates transmural voltage dispersion. The epicardial surface repolarizes early while the endocardium remains depolarized. The voltage gradient between these layers manifests as J-point elevation on the surface ECG.
When the dispersion is severe enough, current flows from the still-depolarized endocardium back to the already-repolarized (and thus re-excitable) epicardium. This can trigger a local re-excitation called Phase 2 reentry, which produces a closely-coupled premature beat that may initiate VF.
The distinction between Brugada syndrome and ERS may be primarily anatomical rather than mechanistic. In Brugada, the affected epicardium is concentrated in the right ventricular outflow tract. In ERS, it is distributed across the inferolateral wall. The underlying ionic mechanism (prominent Ito creating Phase 2 dispersion) appears to be the same.
Management
Short QT Syndrome: The ICD is the primary therapy for patients who have survived cardiac arrest or who have a strong family history of SCD with documented short QT intervals. Quinidine serves as adjunctive pharmacotherapy. It blocks both IKr and Ito, prolonging repolarization and increasing the refractory period. In patients where ICD implantation is not feasible (young children, patient refusal), quinidine may be used as primary prophylaxis.
A practical challenge with ICDs in SQTS: the tall, peaked T waves can cause T-wave oversensing, leading to inappropriate shocks. Programming adjustments (higher detection thresholds, longer detection windows) are often necessary.
Early Repolarization Syndrome: An ICD is indicated for survivors of cardiac arrest. For patients with recurrent VF storms, isoproterenol acutely (to augment the calcium current and restore the epicardial dome) followed by quinidine chronically may suppress the arrhythmia substrate.
The benign ER pattern: No intervention. No restriction. No monitoring beyond standard care. The challenge, and the reason this topic generates clinical anxiety, is distinguishing the benign majority from the rare malignant minority in the absence of a prior event. Currently, there is no reliable way to make this distinction prospectively.
How the EP Lab Tests It
The proof that repolarization is pathologically abbreviated is a QT interval that stays short when the heart rate slows. In a healthy heart, the QT lengthens as the RR interval grows. In Short QT Syndrome the QT is already near its floor, so slowing the rate with exercise recovery or vagal maneuvers barely moves it. We plot QT against RR and see a nearly flat line, and a QTc that holds below 340 ms across rates confirms fixed, accelerated repolarization.
At electrophysiology study we measure this abbreviation directly. The effective refractory period, the shortest coupling interval at which an extrastimulus still captures, is strikingly short: often below 200 ms in the ventricle, and short in the atrium as well, which is why these patients present with early atrial fibrillation. Programmed stimulation frequently induces atrial fibrillation or ventricular fibrillation, sometimes with a single premature extrastimulus. That inducibility is the wavelength problem made visible: a refractory period this short shrinks the reentrant wavelength enough for fibrillation to sustain itself.
Early Repolarization Syndrome shows its malignancy through dynamic behavior. The J-wave in the inferolateral leads is pause-dependent: after a long RR interval, a compensatory pause, or a premature beat, the J-point elevation augments rather than fades. We watch it grow on the monitor across those pauses. This augmentation, read alongside the clinical context of aborted arrest, separates the malignant J-wave syndrome from the benign early repolarization pattern that sits quietly on 5 to 10 percent of normal ECGs.
Key Takeaways
- Short QT Syndrome is caused by gain-of-function potassium channel or loss-of-function calcium channel mutations that shorten the action potential and the effective refractory period.
- A short ERP shrinks the wavelength, allowing small reentrant circuits to sustain themselves; this is why VF, rather than organized VT, is the typical arrhythmia.
- ECG hallmarks of SQTS: QTc < 340 ms, tall peaked narrow-based T waves, and absent or very short ST segments.
- The early repolarization pattern (J-point elevation with QRS notching in inferior/lateral leads) is present in 5-10% of the population and is almost always benign.
- Early Repolarization Syndrome is diagnosed only when the ER pattern coexists with idiopathic VF or cardiac arrest; the mechanism involves epicardial Phase 2 shortening and transmural dispersion.
- Management centers on the ICD for arrest survivors; quinidine is the most useful adjunctive drug because it blocks both IKr and Ito.
Quick Reference
Key Terms
Conduction velocity × refractory period. The minimum circuit size that can sustain reentry.
The portion of a reentrant circuit that has already recovered excitability and is available for re-excitation.
Re-excitation of epicardium by current flowing from endocardium when transmural repolarization dispersion is extreme.
Transient outward potassium current responsible for early Phase 1 repolarization and the action potential notch.
Elevation at the junction of QRS and ST segment; reflects transmural voltage differences during early repolarization.
Core Insight
Long QT kills through triggered activity (EADs during prolonged repolarization). Short QT kills through reentry (abbreviated ERP shrinks the wavelength, allowing VF). Both are repolarization disorders, but their arrhythmia mechanisms are fundamentally different.